Episode
From Guidance to Practice: Updates in CVD Screening - Frankly Speaking Ep 481
- Published
- Apr 20, 2026
- Duration seconds
- 772
- Processing state
not_requested
Actions
POST https://stenobird.com/v1/public/podcasts/frankly-speaking-about-family-medicine-434006/episodes/from-guidance-to-practice-updates-in-cvd-screening-frankly-speaking-ep-481/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/frankly-speaking-about-family-medicine-434006/from-guidance-to-practice-updates-in-cvd-screening-frankly-speaking-ep-481.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-481 Overview: Expand your prevention toolkit with new recommendations for cardiovascular disease screening. Listen in as we discuss how high-sensitivity C-reactive protein (hs-CRP) can guide screening for ongoing inflammation in patients who are at risk, the evidence behind primary and secondary prevention applications, and key limitations to keep in mind when applying these recommendations in practice. Episode resource links: Mensah GA, Arnold N, Prabhu SD, Ridker PM, Welty FK. Inflammation and Cardiovascular Disease: 2025 ACC Scientific Statement: A Report of the American College of Cardiology. J Am Coll Cardiol. Guest: Alan M. Ehrlich, MD, FAAFP Music Credit: Matthew Bugos Thoughts? Suggestions? Email us at [email protected] The views expressed in this podcast are those of Dr. Domino and his guests and do not necessarily reflect the views of Pri-Med.